Pages that link to "Q38752407"

The following pages link to Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment (Q38752407):

Displaying 32 items.

• Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond (Q28068507) (← links)
• Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base (Q28076065) (← links)
• Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy (Q33621804) (← links)
• Seizure control through genetic and pharmacological manipulation of Pumilio in Drosophila: a key component of neuronal homeostasis (Q36244251) (← links)
• A Missense Mutation of the Gene Encoding Synaptic Vesicle Glycoprotein 2A (SV2A) Confers Seizure Susceptibility by Disrupting Amygdalar Synaptic GABA Release (Q37092563) (← links)
• The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy (Q38614499) (← links)
• Evaluation of brivaracetam: a new drug to treat epilepsy (Q38652806) (← links)
• Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide (Q38904679) (← links)
• Computational approaches for innovative antiepileptic drug discovery (Q38907478) (← links)
• Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy (Q38922348) (← links)
• Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII). (Q39006241) (← links)
• Will Brivaracetam Help My Patient? Only Time Will Tell (Q42317849) (← links)
• Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus. (Q46010938) (← links)
• Epilepsy Treatment: A Futurist View (Q47114432) (← links)
• Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neurons (Q47888971) (← links)
• Conformational Preference and Spectroscopical Characteristics of the Active Pharmaceutical Ingredient Levetiracetam. (Q47914322) (← links)
• A resurging boom in new drugs for epilepsy and brain disorders. (Q48093388) (← links)
• Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults. (Q48170445) (← links)
• Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein (Q48383809) (← links)
• Brivaracetam: a novel antiepileptic drug for focal-onset seizures (Q49253776) (← links)
• A review of the pharmacology and clinical efficacy of brivaracetam (Q49700507) (← links)
• An RNAi-mediated screen identifies novel targets for next-generation antiepileptic drugs based on increased expression of the homeostatic regulator pumilio. (Q52714753) (← links)
• Down-regulation of Long Noncoding RNA MALAT1 Protects Hippocampal Neurons Against Excessive Autophagy and Apoptosis via the PI3K/Akt Signaling Pathway in Rats with Epilepsy (Q88956459) (← links)
• Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience (Q90115720) (← links)
• Emerging treatments for progressive myoclonus epilepsies (Q90175159) (← links)
• Brivaracetam in the treatment of epilepsy: a review of clinical trial data (Q90397660) (← links)
• Effects of antiepileptic drugs on cortical excitability in humans: A TMS-EMG and TMS-EEG study (Q90483255) (← links)
• Brivaracetam attenuates pain behaviors in a murine model of neuropathic pain (Q90726399) (← links)
• Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis (Q92641106) (← links)
• A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers (Q92697662) (← links)
• Time course of drug-related treatment-emergent adverse side effects of brivaracetam (Q96438570) (← links)
• Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients (Q99573431) (← links)